Joshua D. Mitchell

Joshua D. Mitchell, MD

Cardiology

Top Doctors®

Specializes in

Cardiotoxicity from cancer therapy, cancer survivorship, cardiomyopathy, prevention, general cardiology, cardiac amyloidosis.

Appointments

Hospital Affiliations

  • Barnes-Jewish Hospital

Experience

Board Certifications

  • Internal Medicine
  • Cardiovascular Disease

Academic Title(s)

Associate Professor, Medicine
Cardiovascular Division
Director, Cardio-Oncology Center of Excellence
Co-Director, Amyloid Center of Excellence

Research Interests

Elucidating the optimal prevention, screening and management of adverse cardiac effects from cancer therapies and improving the diagnosis and management of patients with cardiac amyloid.

Publications & Research

View research profile »

Education

Fellowship, Cardio-oncology

2018 Washington University School of Medicine, St. Louis, MO

Fellowship, Cardiovascular Diseases

2018 Washington University School of Medicine, St. Louis, MO

Residency, Internal Medicine

2011 Walter Reed Army Medical Center, Washington, DC

Medical Degree

2008 University of Texas Southwestern Medical School, Dallas, TX

BS, Biomedical Engineering and Mathematical Science

2000 Johns Hopkins University, Baltimore, MD

Financial Disclosures
  • Pfizer
    • Consulting/Advisory Board: $20,000 - $39,999
    • Reporting Date: 05/01/2026
  • BridgeBio Pharma
    • Consulting/Advisory Board: $10,000 - $19,999
    • Reporting Date: 05/01/2026

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

Is this your profile? Request an edit »